ストックスクリーナーアプリを入手
8.77
4.16%
0.35
アフターアワーズ：
8.81
0.04
+0.46%
前日終値:
$8.42
開ける：
$8.31
24時間の取引高:
13.97M
Relative Volume:
0.83
時価総額：
$9.29B
収益：
$140.98M
当期純損益:
$-854.60M
株価収益率:
-10.27
EPS:
-0.854
ネットキャッシュフロー:
$-299.31M
1週間 パフォーマンス:
-10.51%
1か月 パフォーマンス:
+3.42%
6か月 パフォーマンス:
+6.95%
1年 パフォーマンス:
+257.96%
1日の値動き範囲:
$8.11
$8.90
1週間の範囲:
$8.11
$10.50
52週間の値動き範囲:
$1.95
$12.43
Immunitybio Inc Stock (IBRX) Company Profile
Compare IBRX vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
8.77 | 9.29B | 140.98M | -854.60M | -299.31M | -0.854 |
VRTX
Vertex Pharmaceuticals Inc
|
514.65 | 130.44B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
242.08 | 96.65B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
807.48 | 83.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
869.72 | 54.69B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
384.50 | 43.50B | 5.76B | 514.49M | 1.10B | 4.4813 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-12 | 再開されました | BTIG Research | Buy |
| 2025-05-20 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-10 | 開始されました | BTIG Research | Buy |
| 2023-05-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | 開始されました | Jefferies | Buy |
すべてを表示
Immunitybio Inc (IBRX) 最新ニュース
ImmunityBio, Inc. (IBRX) stock price, news, quote and history - Yahoo Finance UK
FDA Expands ImmunityBio's Anktiva Label in Bladder Cancer - Zacks Investment Research
ImmunityBio Inc. Common Stock (IBRX) Company Profile - Pluang
ImmunityBio director Cheryl Cohen sells $851,088 in shares - Investing.com
ImmunityBio proposes 560,000-share sale: what it means for ImmunityBio stock - AD HOC NEWS
ImmunityBio proposes 560,000-share sale: what it means for ImmunityBio stock - AD HOC NEWS
An officer and director proposes selling 560,000 shares of ImmunityBio (NASDAQ: IBRX). - Stock Titan
A director proposes selling 81,056 ImmunityBio (IBRX) shares, including 55,979 from option exercises. - Stock Titan
IBRX Stock Eyes Worst Week Since July: New Patent Eyes Broader Anktiva Use Ahead Of Lung Cancer Conference - Stocktwits
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Investors to Connect - ACCESS Newswire
U.S. Presidential Envoy Joins Albania’s Religious Leaders to Honor Mother Teresa as Bektashi Order Announces Signed American Cancer-Care Partnership - albaniandailynews.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. Tokenized Stock (Robinhood) to British Pound Sterling Price Today | Live IBRX to GBP Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Japanese Yen Price Today | Live IBRX to JPY Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Indonesian Rupiah Price Today | Live IBRX to IDR Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Chinese Yuan Price Today | Live IBRX to CNY Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to South Korean Won Price Today | Live IBRX to KRW Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Canadian Dollar Price Today | Live IBRX to CAD Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to United States Dollar Price Today | Live IBRX to USD Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Euro Price Today | Live IBRX to EUR Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Vietnamese Dong Price Today | Live IBRX to VND Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Indian Rupee Price Today | Live IBRX to INR Converter & Exchange Rate - CryptoRank
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation | NDAQ:IBRX | Press Release - Stockhouse
IBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease - Stocktwits
Historical Data for ImmunityBio, Inc. Tokenized Stock (Robinhood) in USD - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) Exchanges IBRX Markets | Buy & Sell & Trade - CryptoRank
Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report? - Yahoo Finance
ImmunityBio: None Of The Moonshots Is Priced In (NASDAQ:IBRX) - Seeking Alpha
ImmunityBio, Inc. (IBRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Investors to Connect - accessnewswire.com
IBRX to IDR: ImmunityBio, Inc. • Robinhood Token Price in Indonesian Rupiah - CoinGecko
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Stockholders to Connect - ACCESS Newswire
IBRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ImmunityBio, Inc. (IBRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. Tokenized Stock (Robinhood) Closing Price (USD)Quarterly - CryptoRank
ImmunityBio Stock Short Interest Falls to 31.8% - Quiver Quantitative
ImmunityBio: ANKTIVA Is Real, The Valuation Isn't (NASDAQ:IBRX) - Seeking Alpha
IBRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Does ImmunityBio’s (IBRX) Jim Yong Kim Hire Transform Its Global Access Strategy For Immunotherapies? - simplywall.st
ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitContact Kessler Topaz Meltzer & Check, LLP - Morningstar
ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitContact Kessler Topaz Meltzer & Check, LLP - PR Newswire
ImmunityBio (NASDAQ:IBRX): What Could Shape Its Next Move? - Kalkine Media
ImmunityBio, Inc. (NASDAQ:IBRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Patrick Soon-Shiong to Thomas Ichim: Thanks for Sharing Important Difference Between Il-2 and Il-15 - Oncodaily
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Class A - The National Law Review
ImmunityBio (IBRX) Shares Moved, What Is Behind The Fresh Attention? - Sahm
147,000 Shares in ImmunityBio, Inc. $IBRX Purchased by Hussman Strategic Advisors Inc. - MarketBeat
Does Adding Jim Yong Kim to Leadership Shift ImmunityBio’s Global Strategy Narrative (IBRX)? - simplywall.st
Does Adding Jim Yong Kim to Leadership Shift ImmunityBio’s Global Strategy Narrative (IBRX)? - simplywall.st
Does Adding Jim Yong Kim to Leadership Shift ImmunityBio’s Global Strategy Narrative (IBRX)? - webull.com
Immunitybio Inc (IBRX) 財務データ
収益
当期純利益
現金流量
EPS
Immunitybio Inc (IBRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Simon Barry J. | Officer |
Oct 05 '26 |
Proposed Sale |
13.67 |
560,000 |
7,657,760 |
0 |
| CHERYL COHEN | Director |
Oct 02 '26 |
Proposed Sale |
9.28 |
81,056 |
752,200 |
0 |
| Cohen Cheryl | Director |
Oct 02 '26 |
Option Exercise |
2.98 |
55,979 |
166,817 |
181,365 |
| Cohen Cheryl | Director |
Oct 02 '26 |
Sale |
10.50 |
81,056 |
851,088 |
100,309 |
| CHERYL L COHEN | Officer |
Jul 02 '26 |
Proposed Sale |
9.20 |
131,210 |
1,207,132 |
0 |
| Cohen Cheryl | Director |
Jul 02 '26 |
Option Exercise |
2.98 |
55,979 |
166,817 |
256,596 |
| Cohen Cheryl | Director |
Jul 02 '26 |
Sale |
9.50 |
131,210 |
1,246,941 |
125,386 |
| Selecky Christobel | Director |
Jul 01 '26 |
Sale |
9.02 |
159,478 |
1,439,066 |
0 |
| CHRISTOBEL SELECKY | Director |
Jul 01 '26 |
Proposed Sale |
8.75 |
159,478 |
1,396,230 |
0 |
| Selecky Christobel | Director |
Jul 01 '26 |
Option Exercise |
2.99 |
159,478 |
476,489 |
159,478 |
4.99%
大文字化:
|
ボリューム (24 時間):